Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06031441
Title A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | CAN | AUS

Facility Status City State Zip Country Details
University of Alabama at Birmingham (UAB) RECRUITING Birmingham Alabama 35233 United States Details
Yale Cancer Center RECRUITING New Haven Connecticut 06520 United States Details
Icahn School of Medicine at Mount Sinai (ISMMS) RECRUITING New York New York 10029 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
St Vincent's Hospital Sydney RECRUITING Darlinghurst New South Wales 2010 Australia Details
Peter Maccallum Cancer Centre RECRUITING Melbourne Victoria 3000 Australia Details
British Columbia Cancer Agency - 600 10th Ave W RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 1Z5 Canada Details
St Bartholomew's Hospital RECRUITING London EC1A 7BE United Kingdom Details
The Royal Marsden hospital RECRUITING Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field